Trial Profile
Multicenter Phase I/II Clinical Trial of Recombinant Human Endostatin Continued Pumping Into Vein Combining With Concurrent Chemo-Radiotherapy in the Patients With Unresectable Stage III Non-small-Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms HELPER
- 11 Jul 2017 Status changed from recruiting to completed.
- 03 Jan 2013 New trial record